Finding the fertile woman with phenylketonuria

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 137, Issue 2, 2008, Pages 131-135

  Hanley, William B ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Maternal phenylketonuria; Maternal phenylketonuria embryopathy; Phenylketonuria

Indexed keywords

PHENYLALANINE 4 MONOOXYGENASE;

DIET THERAPY; FEMALE FERTILITY; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; PATHOPHYSIOLOGY; PHENOTYPE; PHENYLKETONURIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 41249099374     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2007.12.011     Document Type: Review

References (42)

1. Levy H.L., and Ghavama M. Maternal phenlyketonuria: a metabolic teratogen. Teratology 53 (1996) 176-184
2. Scriver C.R., Kaufman S., and Woo S.L. The hyperphenylalaninemias. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic & molecular basis of inherited disease (2001), McGraw Hill, New York, NY
3. Knox W.E. An evaluation of the treatment of phenylketonuria with diets low in phenylalanine. Pediatrics 26 (1960) 1-11
4. Paine R.S. The variability in manifestations of untreated patients with PKU. Pediatrics 20 (1957) 290-297
5. Partington M.W. Variations in intelligence in phenylketonuria. CMAJ 86 (1962) 736-743
6. Pitt D. The natural history of untreated phenylketonuria. Med J Aust 1 (1971) 378-383
7. Levy H.L., Karolkewicz V., Houghton S.A., and MacCready R.A. Screening the "normal" population in Massachusetts for phenylketonuria. N Engl J Med 282 (1970) 1455-1458
8. Hanley W.B. Prenatal testing for maternal phenylketonuria (PKU). Int Pediatr 9 Suppl. 1 (1994) 33-39
9. Machill V.G., Seidlitz G., Grimm U., and Knapp A. Zur haufigkeit der phenylketonurie mit narmaler intelligenz. Z Klin Med 45 (1990) 1821-1823
10. Berman J.L., Cunningham G.C., Day R.W., et al. Causes for high phenylalanine with normal tyrosine in newborn screening programs. Am J Dis Child 117 (1969) 54-65
11. Koch R., Acosta P., Shaw K.N.F., et al. In: Bickle, Hudson, and Woolf (Eds). Phenylketonuria and some other inborn errors of metabolism (1971), G (Thyme) Verlag, Stuttgart, Germany 20-25
12. Levy H.L., and Waisbren S.E. Effect of untreated maternal phenylketonuria and hyperphenylalinemia on the fetus. N Engl J Med 309 (1983) 1269-1274
13. Waisbren S.E., Schnell R.R., and Levy H.L. Intelligence and personality characteristics in adults with untreated atypical phenylketonuria and mild hyperphenylalaninemia. J Pediatr 105 (1984) 955-958
14. Weglage J., Ullrich K., Pietsch M., Funders B., Zass R., and Koch H.G. Untreated non-phenylketonuric hyperphenylalaninemia. Intellectual and neurological outcome. Eur J Pediatr 155 Suppl. 1 (1996) S26-S28
15. Smith M.L., Saltzman J., Klim P., Hanley W.B., Feigenbaum A., and Clarke J.T.R. Neuropsychological function in mild hyperphenylalaninemia. Am J Ment Retard 105 (2000) 69-80
16. Schoonheyt W.E., Clarke J.T.R., Hanley W.B., Johnson J.M., and Lehotay D.C. Feto-maternal plasma phenylalanine concentration gradient from 19 weeks gestation to term. Clin Chim Acta 225 (1994) 165-169
17. Weglage J., Moller H.E., Wiederman D., Cipic-Schmidt S., Zschocke J., and Ullrich K. In vivo NMR spectroscopy in patients with phenylketonuria: clinical significance of interindividual differences in brain phenylalanine concentrations. J Inherit Metab Dis 21 (1998) 81-82
18. Moats R.A., Koch R., Moseley K., et al. Brain phenylalanine concentration in the management of adults with phenylketonuria. J Inherit Metab Dis 23 (2000) 7-14
19. Hanley W.B., Clarke J.T.R., and Schoonheyt W.E. Undiagnosed phenylketonuria in adult women: a hidden public health problem. CMAJ 143 (1990) 513-516
20. Hanley W.B., Platt L.D., Bachman R.P., et al. Undiagnosed maternal phenylketonuria: the need for prenatal selective screening or case finding. Am J Obstet Gynecol 180 (1999) 986-994
21. Thibaud D., Ploussard J.P., Vaquant P.O., Chemouny S., and Kleitz T. Diagnosis of phenylketonuria in a 35-year-old mother in relation to prenatal diagnosis of intrauterine growth retardation with mental retardation. Arch Pediatr 5 (1998) 1229-1231
22. Ramesh K.K. Undiagnosed maternal PKU (September 27-October 1, 2000), Irish & American Paediatric Society, Belfast, Ireland [Abstract]
23. Campistol P.J., Arellano P.M., Poo A.P., Escofet S.C., Perez O.P., and Vilaseca B.M.A. Embryonic pathology caused by maternal phenylketonuria. A cause of undiagnosed mental retardation. A report of 8 cases. An Esp Pediatr 51 (1999) 139-142
24. Dahl H.H., Osborn A.H., Hutchison W.M., Thorburn D.R., and Sheffield L.J. Late diagnosis of maternal PKU in a family segregating an arylsulfatase [corrected] E mutation causing chondrodysplasia punctata. Mol Genet Metab 68 (1999) 503-506
25. Starostecka E., Lange A., Piotrowicz M., and Pryzgocka J. A four year observation of three boys with maternal PKU syndrome. J Inherit Metab Dis 24 Suppl. 1 (2001) 17 [Abstract]
26. Knerr I., Zschocke J., Schellmoser S., et al. An exceptional Albanian family with seven children presenting with dysmorphic features and mental retardation: maternal phenylketonuria. BMC Pediatr 5 (2005) 5-8
27. Corsello G., Cicero L., Giuffre M., et al. Maternal hyperphenylalaninemia syndrome: neuropsychological evaluation of four subjects during childhood and adolescence. Minerva Pediatr 58 (2006) 557-569
28. Shaw-Smith C., Hogg S.L., Reading R., Calvin J., and Trump D. Learning and behavioral difficulties but not microcephaly in three brothers resulting from undiagnosed maternal phenylketonuria. Child Care Health Dev 5 (2004) 551-558
29. Gu X.F., and Chen R.G. Current status of newborn screening in China. J Med Screen 6 (1999) 186-187
30. Statistics Canada 2004. Quoted in CMAJ 2006;175:862.
31. Tough S.C., Newburn-Cook C., Johnston D.W., Svenson L.W., Rose S., and Belik J. Delayed childbearing and its impact on population rate changes in low birth weight, multiple births, and preterm delivery. Pediatrics 109 (2002) 399-403
32. Hamilton B.E., Minino A.M., Martin J.A., Kochanek K.D., Strobino D.M., and Guyer B. Annual summary of vital statistics: 2005. Pediatrics 119 (2007) 345-360
33. Breart G., Barros H., Wagener Y., and Prati S. Characteristics of the childbearing population in Europe. Eur J Obstet Gynecol Reprod Biol 111 Suppl. 1 (2003) s45-s52
34. National Institutes of Health Consensus Development Statement: Phenylketonuria. National Institutes of Health Development Panel. Pediatrics 108 (2001) 972-982
35. Robinson M., White F.J., Cleary M.A., Wraith E., Lam W.K., and Walter J.H. Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr 136 (2000) 545-547
36. Koch R., Azen C., Friedman E.G., Fishler K., Bauman-Frischling C., and Lin T. Care of the adult with phenylketonuria. Eur J Pediatr 155 Suppl. 1 (1996) S90-S92
37. Koch R., Burton B., Hoganson G., et al. Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis 25 (2002) 333-346
38. Fisch R.O., Matelon R., Weisberg S., and Michals K. Phenylketonuria: current dietary treatment practices in the United States and Canada. J Am Coll Nutr 16 (1997) 147-151
39. Mowat D.R., Hayden M.C., Thompson S.M., and Wilcken B. Maternal phenylketonuria: a continuing problem. Med J Aust 170 (1999) 592-595
40. Ahn S.S., Cunningham G.C., and Mordaunt V.L. Twenty-two years later: California's maternal PKU program. In: Skells M.R., Buist M.R.M., and Tuerk J.M. (Eds). Proceedings of the neonatal screening symposium. Portland, Ore, May 22-25 (1988) 139-140
41. Gill AE, Amador PS. A retrospective of newborn screening for PKU in New York State 1965-1986, In: Skells MR, Buist MRM Tuerk KM, editors. Proccedings of the national screening symposium. p. 133-4.
42. Waisbren S.E., Doherty L.B., Bailey I.V., et al. The New England maternal PKU project: identification of at risk women. Am J Public Health 78 (1988) 789-792